Astrid Murumägi

4.4k total citations
44 papers, 2.4k citations indexed

About

Astrid Murumägi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Astrid Murumägi has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Immunology. Recurrent topics in Astrid Murumägi's work include Adrenal Hormones and Disorders (7 papers), T-cell and B-cell Immunology (7 papers) and Cancer Cells and Metastasis (5 papers). Astrid Murumägi is often cited by papers focused on Adrenal Hormones and Disorders (7 papers), T-cell and B-cell Immunology (7 papers) and Cancer Cells and Metastasis (5 papers). Astrid Murumägi collaborates with scholars based in Finland, Sweden and Estonia. Astrid Murumägi's co-authors include I. Ots, Peeter Hõrak, Olli Kallioniemi, Pärt Peterson, Tero Aittokallio, Henrik Edgren, Disha Malani, Sara Kangaspeska, Kai Krohn and Kaidi Möll and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Blood.

In The Last Decade

Astrid Murumägi

40 papers receiving 2.4k citations

Peers

Astrid Murumägi
Chang-Ming Bai China
Gregory Hinkle United States
Tokiharu Takahashi Japan
Longtao Wu United States
Esther Caparrós Spain
Justus B. Cohen United States
Jorge L. Martínez‐Torrecuadrada Spain
Sandro J. de Souza Brazil
Jacob-S. Seeler France
Ruth Böhni Switzerland
Chang-Ming Bai China
Astrid Murumägi
Citations per year, relative to Astrid Murumägi Astrid Murumägi (= 1×) peers Chang-Ming Bai

Countries citing papers authored by Astrid Murumägi

Since Specialization
Citations

This map shows the geographic impact of Astrid Murumägi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Murumägi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Murumägi more than expected).

Fields of papers citing papers by Astrid Murumägi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Murumägi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Murumägi. The network helps show where Astrid Murumägi may publish in the future.

Co-authorship network of co-authors of Astrid Murumägi

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Murumägi. A scholar is included among the top collaborators of Astrid Murumägi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Murumägi. Astrid Murumägi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barker, Harlan, et al.. (2024). A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discovery. Nature Chemical Biology. 21(3). 432–442. 9 indexed citations
2.
Paavolainen, Lassi, Harlan Barker, Juuli Raivola, et al.. (2024). Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responses. PubMed. 32(4). 200903–200903. 1 indexed citations
3.
Raivola, Juuli, Kari Salokas, Kaiyang Zhang, et al.. (2023). ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity. Cell Death Discovery. 9(1). 222–222. 10 indexed citations
4.
Turunen, Laura, Antti Hassinen, Lauri Paasonen, et al.. (2023). Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT). SLAS DISCOVERY. 28(4). 138–148. 8 indexed citations
5.
Raivola, Juuli, Hanna Karvonen, Kari Salokas, et al.. (2022). Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention. Cell Death and Disease. 13(8). 714–714. 17 indexed citations
6.
Murumägi, Astrid, Daniela Ungureanu, Mariliina Arjama, et al.. (2021). STRN-ALK rearranged pediatric malignant peritoneal mesothelioma – Functional testing of 527 cancer drugs in patient-derived cancer cells. Translational Oncology. 14(4). 101027–101027. 9 indexed citations
7.
Gebreyohannes, Yemarshet K., Agnieszka Woźniak, Olli Tynninen, et al.. (2018). Anagrelide for Gastrointestinal Stromal Tumor. Clinical Cancer Research. 25(5). 1676–1687. 19 indexed citations
8.
Louhimo, Riku, Bhagwan Yadav, Astrid Murumägi, et al.. (2018). Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy. Molecular Cancer Therapeutics. 17(9). 2060–2071. 32 indexed citations
9.
Sveen, Anita, Jarle Bruun, Peter W. Eide, et al.. (2017). Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies. Clinical Cancer Research. 24(4). 794–806. 173 indexed citations
10.
Mpindi, John Patrick, Bhagwan Yadav, Päivi Östling, et al.. (2016). Consistency in drug response profiling. Nature. 540(7631). E5–E6. 56 indexed citations
11.
Malani, Disha, Astrid Murumägi, Bhagwan Yadav, et al.. (2016). Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML. Leukemia. 31(5). 1187–1195. 44 indexed citations
12.
Kangaspeska, Sara, et al.. (2012). Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms. PLoS ONE. 7(10). e48745–e48745. 59 indexed citations
13.
Edgren, Henrik, Astrid Murumägi, Sara Kangaspeska, et al.. (2011). Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome biology. 12(1). R6–R6. 226 indexed citations
14.
Högnäs, Gunilla, Stefan Veltel, Elina Mattila, et al.. (2011). Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo. Oncogene. 31(31). 3597–3606. 40 indexed citations
15.
Valanne, Susanna, Henna Myllymäki, Jenni Kallio, et al.. (2010). Genome-Wide RNA Interference in Drosophila Cells Identifies G Protein-Coupled Receptor Kinase 2 as a Conserved Regulator of NF-κB Signaling. The Journal of Immunology. 184(11). 6188–6198. 85 indexed citations
16.
Strobel, Oliver, Astrid Murumägi, Reinhild Klein, et al.. (2007). Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS‐1). The Journal of Pathology. 211(5). 563–571. 99 indexed citations
17.
Meager, Anthony, Pärt Peterson, Kaidi Möll, et al.. (2006). Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1. PLoS Medicine. 3(7). e289–e289. 273 indexed citations
18.
Murumägi, Astrid, Olli Silvennoinen, & Pärt Peterson. (2006). Ets transcription factors regulate AIRE gene promoter. Biochemical and Biophysical Research Communications. 348(2). 768–774. 18 indexed citations
19.
Pitkänen, Jukka, Ana Rebane, John Rowell, et al.. (2005). Cooperative activation of transcription by autoimmune regulator AIRE and CBP. Biochemical and Biophysical Research Communications. 333(3). 944–953. 54 indexed citations
20.
Ströbel, Philipp, Andreas Rosenwald, Niklas Beyersdorf, et al.. (2004). Selective loss of regulatory T cells in thymomas. Annals of Neurology. 56(6). 901–904. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang-Ming Bai Breakdown of academic impact, for papers by Gregory Hinkle Breakdown of academic impact, for papers by Tokiharu Takahashi Breakdown of academic impact, for papers by Longtao Wu Breakdown of academic impact, for papers by Esther Caparrós Breakdown of academic impact, for papers by Justus B. Cohen Breakdown of academic impact, for papers by Jorge L. Martínez‐Torrecuadrada Breakdown of academic impact, for papers by Sandro J. de Souza Breakdown of academic impact, for papers by Jacob-S. Seeler Breakdown of academic impact, for papers by Ruth Böhni
Rankless by CCL
2026